Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells
Crossref DOI link: https://doi.org/10.1186/s13058-015-0534-y
Published Online: 2015-03-07
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Min, Ahrum
Im, Seock-Ah
Kim, Debora Keunyoung
Song, Sang-Hyun
Kim, Hee-Jun
Lee, Kyung-Hun
Kim, Tae-Yong
Han, Sae-Won
Oh, Do-Youn
Kim, Tae-You
O’Connor, Mark J
Bang, Yung-Jue
License valid from 2015-03-07